213 results
8-K
EX-10.1
VBIV
VBI Vaccines Inc.
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.
(i) Material
8-K
EX-1.1
i9pfj5v7
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
8-K
EX-10.1
n1f3x3b
5 Jul 23
Entry into a Material Definitive Agreement
4:17pm
8-K
tamk 0h6k14
23 Jun 23
VBI Vaccines Announces Results of Annual General Meeting
4:05pm
8-K
EX-99.1
k2g8rjl3h87rh
23 Jun 23
VBI Vaccines Announces Results of Annual General Meeting
4:05pm